TXMD Stock - TherapeuticsMD, Inc.
Unlock GoAI Insights for TXMD
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $1.76M | $1.30M | $69.96M | $2.57M | $64.87M |
| Gross Profit | $1.76M | $1.30M | $68.57M | $1.17M | $48.90M |
| Gross Margin | 100.0% | 100.0% | 98.0% | 45.5% | 75.4% |
| Operating Income | $-4,760,000 | $-8,523,000 | $1.19M | $-79,577,000 | $-155,541,000 |
| Net Income | $-2,181,000 | $-10,278,000 | $112.00M | $-172,415,000 | $-183,524,000 |
| Net Margin | -123.9% | -789.4% | 160.1% | -6700.9% | -282.9% |
| EPS | $-0.19 | $-0.55 | $-10.35 | $-25.83 | $-38.58 |
TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17ß-estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system. Its preclinical projects include the development of TX-005HR, a progesterone-alone transdermal cream; TX-006HR, an estradiol and progesterone transdermal cream; TX-007HR and TX-008HR, which are transdermal patch product candidates; and TX-009HR, an oral progesterone and estradiol formulation. It also manufactures and distributes branded and generic prescription prenatal vitamins under the vitaTrue, vitaPearl, vitaMedMD, and BocaGreenMD Prena1 brands. The company sells its prescription pharmaceutical products and prenatal vitamin products to wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.
Visit WebsiteEarnings History & Surprises
TXMDEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 11, 2026 | — | — | — | — |
Q4 2025 | Nov 12, 2025 | — | $0.01 | — | — |
Q3 2025 | Aug 12, 2025 | — | $0.05 | — | — |
Q2 2025 | May 13, 2025 | — | $-0.06 | — | — |
Q1 2025 | Mar 27, 2025 | $0.04 | $0.02 | -45.4% | ✗ MISS |
Q4 2024 | Nov 12, 2024 | $0.04 | $-0.05 | -225.0% | ✗ MISS |
Q3 2024 | Aug 12, 2024 | $0.03 | $-0.09 | -400.0% | ✗ MISS |
Q2 2024 | May 10, 2024 | $0.03 | $-0.07 | -333.3% | ✗ MISS |
Q1 2024 | Mar 29, 2024 | $-0.13 | $-0.08 | +38.5% | ✓ BEAT |
Q4 2023 | Nov 14, 2023 | $-0.15 | $-0.13 | +13.3% | ✓ BEAT |
Q3 2023 | Aug 14, 2023 | $-0.07 | $-0.24 | -242.9% | ✗ MISS |
Q2 2023 | May 15, 2023 | $0.06 | $-0.24 | -500.0% | ✗ MISS |
Q1 2023 | Mar 27, 2023 | $-1.11 | $-3.55 | -219.5% | ✗ MISS |
Q4 2022 | Nov 14, 2022 | $-2.04 | $-3.13 | -53.4% | ✗ MISS |
Q3 2022 | Aug 15, 2022 | $-3.04 | $-2.15 | +29.3% | ✓ BEAT |
Q2 2022 | May 16, 2022 | $-3.50 | $-4.72 | -34.9% | ✗ MISS |
Q1 2022 | Mar 10, 2022 | $-3.00 | $-4.50 | -50.0% | ✗ MISS |
Q4 2021 | Nov 11, 2021 | $-5.00 | $-5.50 | -10.0% | ✗ MISS |
Q3 2021 | Aug 4, 2021 | $-5.50 | $-5.50 | 0.0% | = MET |
Q2 2021 | May 6, 2021 | $-5.00 | $-5.50 | -10.0% | ✗ MISS |
Latest News
Frequently Asked Questions about TXMD
What is TXMD's current stock price?
What is the analyst price target for TXMD?
What sector is TherapeuticsMD, Inc. in?
What is TXMD's market cap?
Does TXMD pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to TXMD for comparison